Rafael Ponce

Rafael Ponce has over two decades of experience in preclinical development, with notable positions at Shape Therapeutics, Inc., Juno Therapeutics, Inc., Amgen, and ZymoGenetics. Rafael currently serves as the EVP of Preclinical Development at Shape Therapeutics, Inc., and previously held roles such as Sr. Director at Juno Therapeutics, Inc., Scientific Director at Amgen, and Director of Preclinical Development at ZymoGenetics.